Literature DB >> 11761266

A defined-risks approach to the regulatory assessment of the use of neoplastic cells as substrates for viral vaccine manufacture.

A M Lewis1, P Krause, K Peden.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11761266

Source DB:  PubMed          Journal:  Dev Biol (Basel)        ISSN： 1424-6074


× No keyword cloud information.
  5 in total

Review 1.  Cell culture-based influenza vaccines: A necessary and indispensable investment for the future.

Authors:  Nagendra R Hegde
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Isolation and characterization of cancer stem cells from cervical cancer HeLa cells.

Authors:  Song-Ling Zhang; Yi-Shu Wang; Tong Zhou; Xiao-Wei Yu; Zhen-Tong Wei; Yu-Lin Li
Journal:  Cytotechnology       Date:  2012-03-20       Impact factor: 2.058

3.  Tumors induced in mice by direct inoculation of plasmid DNA expressing both activated H-ras and c-myc.

Authors:  Li Sheng-Fowler; Fang Cai; Haiqing Fu; Yong Zhu; Brian Orrison; Gideon Foseh; Don G Blair; Stephen H Hughes; John M Coffin; Andrew M Lewis; Keith Peden
Journal:  Int J Biol Sci       Date:  2010-03-29       Impact factor: 6.580

4.  An Orally Administered Nonpathogenic Attenuated Vaccine Virus Can Be Used to Control SARS-CoV-2 Infection: A Complementary Plan B to COVID-19 Vaccination.

Authors:  Tibor Bakacs; Volker Sandig; Imre Kovesdi
Journal:  Cureus       Date:  2022-08-27

5.  A mouse strain defective in both T cells and NK cells has enhanced sensitivity to tumor induction by plasmid DNA expressing both activated H-Ras and c-Myc.

Authors:  Li Sheng-Fowler; Wei Tu; Haiqing Fu; Haruhiko Murata; Lynda Lanning; Gideon Foseh; Juliete Macauley; Donald Blair; Stephen H Hughes; John M Coffin; Andrew M Lewis; Keith Peden
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.